Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719834 · ClinicalTrials.gov registry record
Behavioral Expressions in Alzheimer's Disease
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 4
- Enrollment target
NCT02719834: Completed study, sponsored by University of Florida.
NCT02719834 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02719834 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Behavioral expressions, such as agitation and aggression, affect up to 90% of persons with dementia and are a major source of patient and caregiver distress, nursing home placement, anti-psychotic medication use, restraints, and increased health care costs. The purpose of the research study is to investigate whether reducing pain reduces behavioral expressions of Alzheimer's disease (agitation and aggression).
Primary Outcome
The MOBID-2 is a two-part, observational pain behavior measure. Part 1 assesses pain related to the musculoskeletal system (the most common cause of pain in older adults) during a set of standardized, guided movements during morning care (5 items). Part 2 assesses pain that might originate from internal organs, head, and skin and is monitored over time (5 items). If a pain behavior is detected, pain intensity is rated using a 0-10 numerical rating scale.
Interventions
- DRUG Acetaminophen
- OTHER Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-02 |
What the finished NCT02719834 record still lists
NCT02719834 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT02719834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02719834 about?
NCT02719834 is a clinical study titled "Behavioral Expressions in Alzheimer's Disease". Behavioral expressions, such as agitation and aggression, affect up to 90% of persons with dementia and are a major source of patient and caregiver distress, nursing home placement, anti-psychotic medication use, restraints, and increased health care costs. The purpose of the research study is to in...
What is the current status of trial NCT02719834?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2016-04. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02719834?
The interventions under investigation include: Acetaminophen (DRUG), Placebo (OTHER).
Who is sponsoring clinical trial NCT02719834?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia